H) where the injection will be given Figure G: top of the arm Step 15
GLP-1s may help vascular and lymphatic health, but they wont repair structural lymphatic damage on their own
Chen W, Qin H, Zhou Z, Chen Y, Xu X, Chen Y, et al
Semaglutide has a different structure from another GLP-1 receptor agonist, liraglutide 3 mg (Saxenda, Novo Nordisk), a once-daily injection FDA approved for weight management in 2014
Its dual-receptor mechanism provides comprehensive metabolic modulation without need for additional peptide combinations
Mechanistically, OAT not only promotes TGF-1 activation but also enhances Smad and non-Smad signaling, supporting sustained fibrotic responses